David A. Siegel Cytosorbents Corp Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.2 - $2.46 $13,080 - $26,814	-10,900 Reduced 39.64%	16,600 $23,000
Q2 2022 Aug 15, 2022	BUY	$1.76 - $3.22 $17,600 - $32,200	10,000 Added 57.14%	27,500 $60,000
Q1 2022 May 16, 2022	SELL	$2.88 - $4.23 $126,144 - $185,274	-43,800 Reduced 71.45%	17,500 $56,000
Q4 2021 Feb 14, 2022	SELL	$4.05 - $8.11 $112,185 - $224,646	-27,700 Reduced 31.12%	61,300 $257,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $9.71 $366,100 - $507,833	-52,300 Reduced 37.01%	89,000 $723,000
Q2 2021 Aug 16, 2021	SELL	$7.55 - $9.42 $553,415 - $690,486	-73,300 Reduced 34.16%	141,300 $1.07 Million
Q1 2021 May 17, 2021	BUY	$8.23 - $11.48 $555,525 - $774,900	67,500 Added 45.89%	214,600 $1.86 Million
Q4 2020 Feb 16, 2021	SELL	$7.65 - $8.98 $366,435 - $430,142	-47,900 Reduced 24.56%	147,100 $1.17 Million
Q3 2020 Nov 16, 2020	BUY	$7.37 - $11.54 $420,827 - $658,934	57,100 Added 41.41%	195,000 $1.56 Million
Q2 2020 Aug 14, 2020	BUY	$6.28 - $10.59 $172,072 - $290,166	27,400 Added 24.8%	137,900 $1.37 Million
Q1 2020 May 15, 2020	SELL	$3.77 - $7.73 $102,544 - $210,256	-27,200 Reduced 19.75%	110,500 $854,000
Q4 2019 Feb 14, 2020	BUY	$3.61 - $5.22 $112,271 - $162,342	31,100 Added 29.17%	137,700 $530,000
Q3 2019 Nov 14, 2019	SELL	$4.33 - $7.63 $63,218 - $111,398	-14,600 Reduced 12.05%	106,600 $536,000
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.78 $60,384 - $79,356	-10,200 Reduced 7.76%	121,200 $801,000
Q1 2019 May 15, 2019	SELL	$6.82 - $8.56 $54,560 - $68,480	-8,000 Reduced 5.74%	131,400 $995,000
Q4 2018 Feb 14, 2019	SELL	$7.05 - $12.64 $203,745 - $365,296	-28,900 Reduced 17.17%	139,400 $1.13 Million
Q3 2018 Nov 14, 2018	SELL	$10.95 - $14.8 $502,068 - $678,594	-45,851 Reduced 21.41%	168,300 $2.17 Million
Q2 2018 Aug 14, 2018	BUY	$6.9 - $12.35 $1.48 Million - $2.64 Million	214,151 New	214,151 $2.44 Million

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.7M

Call Options Held

15.4K

Put Options Held

Avenir Corp Washington, DC

2.98M
Shares

$3.09 Million
0.45% of portfolio
Skylands Capital, LLC

2.76M
Shares

$2.87 Million
0.6% of portfolio
Granahan Investment Management, LLC Waltham, MA

2.09M
Shares

$2.18 Million
0.13% of portfolio
Vanguard Group Inc Valley Forge, PA

1.95M
Shares

$2.03 Million
0.0% of portfolio
Neuberger Berman Group LLC New York, NY

1.78M
Shares

$1.85 Million
0.0% of portfolio

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $45.3M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account